Aytu Biopharma (AYTU) Restructuring Costs (2020 - 2024)

Aytu Biopharma (AYTU) has 3 years of Restructuring Costs data on file, last reported at $1.3 million in Q4 2024.

• On a quarterly basis, Restructuring Costs changed N/A year-over-year to $1.3 million in Q4 2024; TTM through Sep 2025 was $1.3 million, a 55.2% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 2.55% from the prior year.
• Restructuring Costs for Q4 2024 stood at $1.3 million, up from $784000.0 in the prior quarter.
• Over the last five years, Restructuring Costs for AYTU reached as high as $2.9 million in Q1 2021 and fell as low as -$2.0 million in Q2 2021.
• Historically, Restructuring Costs has averaged $817233.6 across 3 years, with a median of $784000.0 in 2024.
• On a YoY basis, Restructuring Costs climbed as much as 832.23% in 2021 and fell as far as 468.35% in 2021.
• Year by year, Restructuring Costs stood at $1.3 million in 2020, then slumped by 249.09% to -$2.0 million in 2021, then soared by 167.33% to $1.3 million in 2024.
• Per Business Quant data, the three most recent Restructuring Costs figures were $1.3 million in Q4 2024, $784000.0 in Q3 2024, and $1.9 million in Q2 2024.